Palmoplantar pustulosishttps://en.wikipedia.org/wiki/Pustulosis_palmaris_et_plantaris
Palmoplantar pustulosis chirwere chisingaperi chinoramba chichidzokororwa (kureva, pustulosis kana pustular psoriasis) chinowanikwa pamichindwe nemakumbo chete, uye chinoratidzirwa histologically ne intraepidermal pustules dzakazara neutrophils. Kushandiswa kwe systemic retinoids chete, pamwe chete nemusanganiswa ne photochemotherapy, kunobatsira kuvandudza zviratidzo zve palmoplantar pustulosis.

○ Kurapwa
Acitretin yemumuromo inoshanda kune iyi mhando ye psoriasis.
#Acitretin
☆ AI Dermatology — Free Service
Mune 2022 Stiftung Warentest mhedzisiro kubva kuGermany, kugutsikana kwevatengi neModelDerm kwakangodzikira zvishoma pane nekubhadharwa kwe telemedicine kubvunzana.
  • Muchiitiko ichi, pompholyx inogona zvakare kufungidzirwa.
  • Mukushaikwa kwemapustules, eczema yeruoko inogonawo kutorwa seyakasiyana pakuongororwa.
References Palmoplantar Psoriasis 28846363 
NIH
Palmoplantar psoriasis imhando ye psoriasis inonyanya kukanganisa ganda pazvanza zvako uye pasi. Inoratidza ganda rakakora, rakaoma, kuputika, kana musanganiswa wemhando mbiri.
Palmoplantar psoriasis is a variant of psoriasis that characteristically affects the skin of the palms and soles. It features hyperkeratotic, pustular, or mixed morphologies.
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).